CONMED Corporation CNMD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 73.43M | 56.50M | 54.85M | 47.06M | 64.07M |
| Total Depreciation and Amortization | 74.72M | 74.14M | 73.67M | 73.08M | 72.04M |
| Total Amortization of Deferred Charges | 5.68M | 6.35M | 6.68M | 6.85M | 6.95M |
| Total Other Non-Cash Items | 44.95M | 43.76M | 43.84M | 55.16M | 43.95M |
| Change in Net Operating Assets | -52.46M | -30.15M | -36.40M | -11.45M | -19.31M |
| Cash from Operations | 146.31M | 150.59M | 142.63M | 170.69M | 167.69M |
| Capital Expenditure | -13.62M | -16.12M | -18.92M | -19.81M | -18.74M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 22.31M | 21.50M | 7.00M | -- | -- |
| Other Investing Activities | -2.00M | -2.00M | -2.00M | -1.15M | 850.00K |
| Cash from Investing | 6.69M | 3.38M | -13.92M | -20.96M | -17.89M |
| Total Debt Issued | 1.40B | 1.40B | 734.67M | 720.67M | 683.67M |
| Total Debt Repaid | -1.43B | -1.44B | -769.67M | -795.25M | -774.25M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -49.42M | -43.22M | -37.02M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.19M | -12.38M | -18.57M | -24.75M | -24.73M |
| Other Financing Activities | -54.70M | -50.91M | -39.39M | -36.49M | -34.20M |
| Cash from Financing | -143.11M | -149.68M | -129.98M | -135.82M | -149.52M |
| Foreign Exchange rate Adjustments | -848.00K | -889.00K | 812.00K | 2.45M | 175.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.04M | 3.39M | -455.00K | 16.36M | 462.00K |